Takada, Masahiro http://orcid.org/0000-0002-5954-1296
Imoto, Shigeru
Ishida, Takanori
Ito, Yoshinori
Iwata, Hiroji
Masuda, Norikazu
Mukai, Hirofumi
Saji, Shigehira
Ikeda, Takafumi
Haga, Hironori
Saeki, Toshiaki
Aogi, Kenjiro
Sugie, Tomoharu
Ueno, Takayuki
Ohno, Shinji
Ishiguro, Hiroshi
Kanbayashi, Chizuko
Miyamoto, Takeshi
Hagiwara, Yasuhiro
Toi, Masakazu
Funding for this research was provided by:
Taiho Pharmaceutical
Article History
Received: 6 July 2023
Accepted: 17 August 2023
First Online: 7 September 2023
Declarations
:
: MTa received grants from Taiho (Tokyo, Japan) during the conduct of the study and has received grants from AstraZeneca (Osaka, Japan), Daiichi Sankyo (Tokyo, Japan), Eisai (Tokyo, Japan), Yakult (Tokyo, Japan), Medbis (Kyoto, Japan), the Japan Breast Cancer Research Group Association (JBCRG), the Kyoto Breast Cancer Research Network (KBCRN), ABCSG, and IQVIA Japan; and personal fees from Chugai (Tokyo, Japan), AstraZeneca, Daiichi Sankyo, Taiho, Pfizer (Tokyo, Japan), Eli Lilly (Kobe, Japan), Eisai, and MSD (Tokyo, Japan). HIw has received consulting fees from Daiichi Sankyo, Chugai, Lilly, AstraZeneca, Pfizer, MSD, and Novartis; and received personal fees from Daiichi Sankyo, Chugai, AstraZeneca, Lilly, MSD, Pfizer, and Taiho. NM has received grants from Chugai, AstraZeneca, MSD, Pfizer, Eli Lilly, Kyowa Kirin, Eisai, Novartis, Sanofi (Tokyo, Japan), Daiichi Sankyo, and Nippon Kayaku; and personal fees from Chugai, AstraZeneca, Pfizer, Elli Lilly, Eisai, and Takeda. NM is also a member of the board of directors of the Japan Breast Cancer Society (JBCS) and JBCRG. HM has received grants from Daiichi Sankyo, and Eisai; and personal fees from Taiho, Daiichi Sankyo, and Takeda. SS has received grants from AstraZeneca, Chugai, Daiichi Sankyo, MSD, and Taiho; and personal fees from AstraZeneca, Chugai, Daiichi Sankyo, Eisai, Eli Lilly, Kyowa Kirin, MSD, Novartis, Ono (Osaka, Japan), Pfizer, Taiho, and Takeda. SS also received advisory fees from AstraZeneca, Chugai, Daiichi Sankyo, MSD, and Pfizer. TSa has received grants from Maruho, LabCorp Japan, Sanofi, Takeda, Novartis, MSD, Sawai, Covance Japan, Taiho, WJOG, Chugai, Nippon Kayaku, AstraZeneca, Eisai, Kyowa Kirin, Daiichi Sankyo, and Eli Lilly; and personal fees from Ono, Kyowa Kirin, Chugai, ASKA, Novartis, AstraZeneca, Eisai, Taiho, Takeda, Eli Lilly, Pfizer, MiRTeL, and Meiji Seika. KA has received personal fees from Chugai, Eisai, AstraZeneca, Taiho, Daiichi Sankyo, Pfizer, and Eli Lilly; and research grant from Chugai, Eisai, and Takeda. TSu has received research grants from Chugai, Eisai, and Kyoto Bridge. For Breakthrough Medicine (KBBM); and personal fees from Chugai, MSD, AstraZeneca, Pfizer, Eli Lillym Taiho, Daiichi Sankyo, and Eisai. TU has received personal fees from Chugai, Eisai, AstraZeneca, and Novartis; and research grant from Eli lilly. SO has received personal fees from Chugai, MSD, Eli Lilly, and Nippon Kayaku. HI has received personal fees from JMS, Eisai, Pfizer, Chugai, Kyowa Kirin, and Daiichi Sankyo; and research grant from Eisai, Daiichi Sankyo, Chugai, Nipro, and Takeda. MTo received grants from Taiho during the conduct of the study and has received grants from Chugai, Takeda, Pfizer, Taiho, JBCRG, KBCRN, Eisai, Eli Lilly, Daiichi Sankyo, AstraZeneca, Astellas (Tokyo, Japan), Shimadzu (Kyoto, Japan), Yakult, Nippon Kayaku, AFI technology, Luxonus (Kawasaki, Japan), Shionogi, GL Science, and Sanwa Shurui; personal fees from Chugai, Takeda, Pfizer, Kyowa Kirin, Taiho, Eisai, Daiichi Sankyo, AstraZeneca, Eli Lilly, MSD, Exact Science (Tokyo, Japan), Novartis, Shimadzu, Yakult, Nippon Kayaku, Devicore and Sysmex; and advisory fees from Daiichi Sankyo, Eli Lilly, BMS (Tokyo, Japan), Athenex Oncology, Bertis, Terumo (Tokyo, Japan), and Kansai Medical Net. MTo is also a member of the board of directors of JBCRG, KBCRN, and Organisation for Oncology and Translational Research. The other authors declare no other potential conflicts of interest.
: The trial protocol was approved by the institutional review board of each study site.
: This study was conducted in accordance with the provisions of the Declaration of Helsinki and its later amendments. Written informed consent was obtained from all patients.
: Not applicable.